Total Payments
$10,746
2024 Payments
$1,245
Companies
58
Transactions
616
Medicare Patients
19,738
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$10,735 (99.9%)
Education$10.80 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,735 | 615 | 99.9% |
| Education | $10.80 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,561 | 94 | $0 (2024) |
| Novo Nordisk Inc | $1,383 | 79 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,127 | 67 | $0 (2024) |
| ABBVIE INC. | $825.65 | 43 | $0 (2024) |
| PFIZER INC. | $811.93 | 63 | $0 (2024) |
| Lilly USA, LLC | $469.87 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $340.11 | 20 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $332.98 | 24 | $0 (2022) |
| Amarin Pharma Inc. | $322.17 | 16 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $297.11 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,245 | 57 | AstraZeneca Pharmaceuticals LP ($207.55) |
| 2023 | $1,218 | 63 | GlaxoSmithKline, LLC. ($265.94) |
| 2022 | $1,499 | 81 | GlaxoSmithKline, LLC. ($229.48) |
| 2021 | $1,385 | 79 | AbbVie Inc. ($449.40) |
| 2020 | $1,073 | 61 | AstraZeneca Pharmaceuticals LP ($207.29) |
| 2019 | $1,248 | 81 | Novo Nordisk Inc ($259.18) |
| 2018 | $1,409 | 93 | AstraZeneca Pharmaceuticals LP ($289.58) |
| 2017 | $1,668 | 101 | AstraZeneca Pharmaceuticals LP ($294.92) |
All Payment Transactions
616 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Vaccines | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Oncology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Neurology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: VACCINES | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: Medical Device | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2024 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Vaccines | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Gastroenterology | ||||||
| 08/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Inflammation | ||||||
| 07/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Neurology | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 4,969 | 7,520 | $824,140 | $422,607 |
| 2022 | 37 | 5,102 | 7,909 | $872,075 | $449,365 |
| 2021 | 30 | 4,740 | 7,967 | $803,970 | $419,269 |
| 2020 | 33 | 4,927 | 8,148 | $671,145 | $370,119 |
Total Patients
19,738
Total Services
31,544
Medicare Billing
$1.7M
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 578 | 1,329 | $265,800 | $145,783 | 54.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 371 | 738 | $129,150 | $59,381 | 46.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 287 | 287 | $86,100 | $42,757 | 49.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 268 | 270 | $27,000 | $19,411 | 71.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 240 | 247 | $37,050 | $17,783 | 48.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 204 | 302 | $24,050 | $15,249 | 63.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 652 | 1,716 | $17,160 | $14,406 | 84.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 330 | 333 | $16,650 | $11,981 | 72.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 66 | 72 | $18,000 | $11,583 | 64.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 318 | 320 | $32,000 | $10,571 | 33.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 103 | 129 | $19,300 | $10,181 | 52.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 36 | 36 | $12,600 | $10,136 | 80.4% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 50 | 80 | $14,000 | $7,577 | 54.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 376 | 434 | $26,040 | $5,468 | 21.0% |
| 92587 | Placement of ear probe for computerized measurement of sound with interpretation and report | Office | 2023 | 292 | 292 | $29,200 | $5,351 | 18.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 28 | 28 | $8,400 | $5,253 | 62.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 23 | 23 | $6,900 | $4,396 | 63.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $10,200 | $4,146 | 40.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 25 | 25 | $3,750 | $3,270 | 87.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 37 | 37 | $2,775 | $2,720 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 66 | 66 | $3,300 | $2,375 | 72.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 54 | 64 | $6,400 | $2,216 | 34.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 37 | 46 | $5,750 | $1,751 | 30.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 56 | 56 | $2,800 | $1,664 | 59.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 12 | $2,400 | $1,403 | 58.5% |
About Dr. Albert Ferrara, DO
Dr. Albert Ferrara, DO is a Internal Medicine healthcare provider based in East Meadow, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205940434.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Ferrara, DO has received a total of $10,746 in payments from pharmaceutical and medical device companies, with $1,245 received in 2024. These payments were reported across 616 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($10,735).
As a Medicare-enrolled provider, Ferrara has provided services to 19,738 Medicare beneficiaries, totaling 31,544 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location East Meadow, NY
- Active Since 08/17/2006
- Last Updated 02/04/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205940434
Products in Payments
- FARXIGA (Drug) $1,248
- TRELEGY ELLIPTA (Drug) $636.95
- Ozempic (Drug) $562.75
- XIFAXAN (Drug) $403.01
- UBRELVY (Drug) $401.76
- MOUNJARO (Drug) $334.89
- Livalo (Drug) $332.98
- Vascepa (Drug) $322.17
- Victoza (Drug) $300.14
- CHANTIX (Drug) $290.28
- Saxenda (Drug) $243.25
- SHINGRIX (Biological) $230.49
- JANUVIA (Drug) $220.32
- Trintellix (Drug) $214.77
- XARELTO (Drug) $168.57
- VRAYLAR (Drug) $160.89
- GEMTESA (Drug) $154.71
- ELIQUIS (Drug) $148.22
- JARDIANCE (Drug) $146.95
- INTERSTIM (Device) $143.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Meadow
Myron Zitt, Md, MD
Internal Medicine — Payments: $151,260
Internal Medicine $151,260
Dr. Mohammad Aslam, M.d, M.D
Internal Medicine — Payments: $21,179
Internal Medicine $21,179
Dr. Andre Giannakopoulos, M.d, M.D
Internal Medicine — Payments: $10,477
Internal Medicine $10,477
Dr. Alexander Frangas, M.d, M.D
Internal Medicine — Payments: $9,686
Internal Medicine $9,686
Kecia Ford, M.d, M.D
Internal Medicine — Payments: $7,764
Internal Medicine $7,764
Dr. Jaime Simon-Marshak, Md, MD
Internal Medicine — Payments: $6,829
Internal Medicine $6,829